$0.000001
At close: Mar 6, 9:30 AM EDT
Comments
Loading...
Infinity Pharmaceuticals Analyst Ratings and Price Targets | OTC:INFIQ | Benzinga
Infinity Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Infinity Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Infinity Pharmaceuticals
Data brought to you by Benzinga APIs
FAQ
What is the target price for Infinity Pharmaceuticals (INFIQ) stock?
There is no price target for Infinity Pharmaceuticals
What is the most recent analyst rating for Infinity Pharmaceuticals (INFIQ)?
There is no analyst for Infinity Pharmaceuticals
When was the last upgrade for Infinity Pharmaceuticals (INFIQ)?
There is no last upgrade for Infinity Pharmaceuticals
When was the last downgrade for Infinity Pharmaceuticals (INFIQ)?
There is no last downgrade for Infinity Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Infinity Pharmaceuticals (INFIQ)?
There is no next analyst rating for Infinity Pharmaceuticals.
Is the Analyst Rating Infinity Pharmaceuticals (INFIQ) correct?
There is no next analyst rating for Infinity Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.